Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 37 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems has received an order to extend the clinical database system and install its new Data Analysis System at the Al Babtain Hospital, Dammam, Saudi Arabia. Dendrite’s unique clinical database system includes four types of analytics and reports:
The positive outcomes from the UK-ROPE (Registry of prostate embolization) – a collaboration initiated by British Society of Interventional Radiology (BSIR) and Dendrite Clinical Systems – has resulted in a National Institute of Health and Care Excellence (NICE) recommendation that prostate artery embolization (PAE) should be made available by the NHS.
Dendrite Clinical Systems and the British Obesity & Metabolic Surgery Society (BOMSS) have launched Version 2 of the National Bariatric Surgical Registry, which includes several enhancements and changes improving the data collected and reporting.
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 36 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems has received an order from NHS Wales to expand the successful Regional Lung Cancer Registry in North Wales to cover the whole of the country, established the Welsh National Lung Cancer Pleural Nodules Registry. The registry is designed for health professionals to collect, view and use real-time data about their patients with pleural disease.
Dendrite and UK research groups launch MASCOT Registry
Dendrite Clinical Systems – in collaboration with Haemotology Cancer Care (UCLH Charity), the Royal Free Charity, HaemSTAR (an organisation researching non-malignant haematology) and MPN Voice – have launched the MASCOT (Myeloproliferative Neoplasm Splanchnic Vein Thrombosis, MPN-SVT) Registry, a UK wide registry for patients with myeloproliferative diseases suffering from splanchnic or abdominal vein thrombosis.
Myeloproliferative neoplasms are a group of hematopoietic stem cell disorders characterised by clonal proliferation of myeloid-lineage cells. Arterial and venous thromboses are a major cause of morbidity in Ph-negative MPNs. Venous thrombosis may occur at unusual anatomic sites, such as splanchnic vein thrombosis or cerebral sinus thrombosis. SVT refers to thrombosis formation in the portal venous system (portal vein thrombosis, PVT), hepatic venous system Budd-Chiari syndrome (BCS), splenic venous system or mesenteric venous system1.
This prospective web-based patient registry that will collect, record and analyse the treatment and outcomes of patients with this condition.
“We are delighted to launch the MASCOT Registry,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “Myeloproliferative neoplasms are the most common underlying prothrombotic disorder found in patients with splanchnic vein thrombosis and the registry will provide valuable information on how to manage this prothrombotic disorder.
To better understand current practice, this online registry was developed by Dendrite using their “Intellect Web” software. This allows users to enter patient data online, using a range of modern html-5 compatible web browsers, without the need to install additional software or perform any complex system configurations.
Reference
- Ther Adv Hematol. 2017 Mar; 8(3): 107–118.
